Director's forum - understanding the food and drug administration risk evaluation and mitigation strategies (REMS)
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Works matching IS 00185787 AND DT 2010 AND VI 45 AND IP 7
Results: 15
1
2
Current FDA-related drug information.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
3
Formulary Drug Reviews - Liraglutide.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 7, p. 552, doi. 10.1310/hpj4507-552
- By:
- Publication type:
- Article
4
A Patient Case: Intravenous Azithromycin-Induced Hepatotoxicity.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 7, p. 545, doi. 10.1310/hpj4507-545
- By:
- Publication type:
- Article
5
ISMP Adverse Drug Reactions - Low Molecular Weight Heparin–Induced Thrombocytopenia; Hepatotoxicity in a Child Caused by Trimethoprim-Sulfamethoxazole; Pseudopheochromocytoma Caused by Glaucoma Eye Drops; Efalizumab-Induced Inflammatory Polyarthritis; Cardiotoxicity and Other Adverse Drug Events Associated with Mitoxantrone; Long-Acting Beta-Agonists and Catastrophic Asthma Events; Interruptions and Increased Risk and Severity of Medication Errors
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 7, p. 521, doi. 10.1310/hpj4507-521
- By:
- Publication type:
- Article
6
Current FDA-Related Drug Information - New Drugs Approved by the FDA; New Dosage Forms and Indications Approved by the FDA; Agents Pending FDA Approval; Supplemental Applications Filed by Manufacturer; Significant Labeling Changes or “Dear Health Professional” Letters Related to Safety
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 7, p. 567, doi. 10.1310/hpj4507-567
- By:
- Publication type:
- Article
7
Director’s Forum - Understanding the Food and Drug Administration Risk Evaluation and Mitigation Strategies (REMS).
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 7, p. 576, doi. 10.1310/hpj4507-576
- By:
- Publication type:
- Article
8
ISMP Medication Error Report Analysis - Oral Syringes: A Crucial and Economical Risk-Reduction Strategy That Has Not Been Fully Utilized.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 7, p. 518, doi. 10.1310/hpj4507-518
- By:
- Publication type:
- Article
9
Cancer Chemotherapy Update - Epirubicin, Cisplatin, and Capecitabine (ECX) Regimen.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 7, p. 527, doi. 10.1310/hpj4507-527
- By:
- Publication type:
- Article
10
Influence of an Institution-Specific Sepsis Protocol on the Adequacy of Empiric Antimicrobial Therapy.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 7, p. 538, doi. 10.1310/hpj4507-538
- By:
- Publication type:
- Article
11
Variable Infusion Rates Associated With TKO/KVO Abbreviations: A Survey of Illinois Hospital Pharmacists.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 7, p. 549, doi. 10.1310/hpj4507-549
- By:
- Publication type:
- Article
12
Pharmacy Automation and Technology - Getting Value From Blogs and Other Web Resources.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 7, p. 572, doi. 10.1310/hpj4507-572
- By:
- Publication type:
- Article
13
Editorial - Peer Review Program for Students and Residents.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 7, p. 516, doi. 10.1310/hpj4507-516
- By:
- Publication type:
- Article
14
Hospital Pharmacy Pulse - Recent Publications on Medications and Pharmacy.
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 7, p. 581, doi. 10.1310/hpj4507-581
- By:
- Publication type:
- Article
15
Off-Label Drug Uses - Ondansetron (Oral): Uremic Pruritus (Adults).
- Published in:
- Hospital Pharmacy, 2010, v. 45, n. 7, p. 534, doi. 10.1310/hpj4507-534
- By:
- Publication type:
- Article